Skip to main navigation Skip to search Skip to main content

Asparaginyl peptide ligase-mediated radiolabelling of single-domain antibodies

Research output: Patent

Abstract

The invention generally relates to the field of radiochemistry. In particular, the present invention provides an asparaginyl peptide ligase (PAL)-mediated method of producing site- specifically radiolabeled single-domain antibody (sdAb) tracers, optionally in the presence of a glutaminyl cyclase (QC). The radiolabelled sdAb tracers prepared by the method of the present invention provide enhanced characteristics and are suitable for use in diagnosis, in surgery, in treatment, in therapy monitoring, and as an imaging agent.
Original languageEnglish
Patent numberEP4673554A1
Publication statusPublished - 2026

Fingerprint

Dive into the research topics of 'Asparaginyl peptide ligase-mediated radiolabelling of single-domain antibodies'. Together they form a unique fingerprint.

Cite this